{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:33:28Z","timestamp":1791084808214,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,7]],"date-time":"2014-03-07T00:00:00Z","timestamp":1394150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/09\/052\/27833"],"award-info":[{"award-number":["PG\/09\/052\/27833"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/12\/76\/29852"],"award-info":[{"award-number":["PG\/12\/76\/29852"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G1002082"],"award-info":[{"award-number":["G1002082"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jmmc-online.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.yjmcc.2014.03.002","type":"journal-article","created":{"date-parts":[[2014,3,14]],"date-time":"2014-03-14T19:00:48Z","timestamp":1394823648000},"page":"104-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Targeted deletion of ERK2 in cardiomyocytes attenuates hypertrophic response but provokes pathological stress induced cardiac dysfunction"],"prefix":"10.1016","volume":"72","author":[{"given":"Susanne","family":"Ulm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoyee","family":"Tsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjoy K.","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhpal","family":"Prehar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoxi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Cartwright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2014.03.002_bb0005","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1056\/NEJMra072139","article-title":"Cardiac plasticity","volume":"358","author":"Hill","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0010","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.pcl.2004.04.017","article-title":"Hypertrophic cardiomyopathy in childhood","volume":"51","author":"Maron","year":"2004","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0015","first-page":"669","article-title":"PTPN11 mutations and genotype-phenotype correlations in Noonan and LEOPARD syndromes","volume":"2","author":"Ogata","year":"2005","journal-title":"Pediatr Endocrinol Rev"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0020","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0735-1097(93)90436-5","article-title":"Cardiologic abnormalities in Noonan syndrome: phenotypic diagnosis and echocardiographic assessment of 118 patients","volume":"22","author":"Burch","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0025","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ng772","article-title":"Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome","volume":"29","author":"Tartaglia","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0030","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nm1084","article-title":"Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation","volume":"10","author":"Araki","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0035","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/humu.20005","article-title":"Noonan syndrome-associated SHP2\/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2\/MAPK1 activation","volume":"23","author":"Fragale","year":"2004","journal-title":"Hum Mutat"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0040","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1172\/JCI30756","article-title":"Mediating ERK 1\/2 signaling rescues congenital heart defects in a mouse model of Noonan syndrome","volume":"117","author":"Nakamura","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0045","doi-asserted-by":"crossref","first-page":"18930","DOI":"10.1073\/pnas.0806556105","article-title":"Role of ERK1\/2 signaling in congenital valve malformations in Noonan syndrome","volume":"105","author":"Krenz","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0050","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1074\/jbc.M513068200","article-title":"PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects","volume":"281","author":"Kontaridis","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0055","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.febslet.2006.03.088","article-title":"Reduced phosphatase activity of SHP-2 in LEOPARD syndrome: consequences for PI3K binding on Gab1","volume":"580","author":"Hanna","year":"2006","journal-title":"FEBS Lett"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0060","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1172\/JCI44972","article-title":"Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation","volume":"121","author":"Marin","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0065","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nrm1498","article-title":"The RAF proteins take centre stage","volume":"5","author":"Wellbrock","year":"2004","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0070","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1161\/01.CIR.0000138190.50127.6A","article-title":"Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload","volume":"110","author":"Harris","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0075","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1172\/JCI200420317","article-title":"Cardiac-specific disruption of the c-raf-1 gene induces cardiac dysfunction and apoptosis","volume":"114","author":"Yamaguchi","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0080","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1749-6632.2009.05088.x","article-title":"Extracellular signal-regulated kinase 1\/2 (ERK1\/2) signaling in cardiac hypertrophy","volume":"1188","author":"Kehat","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0085","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1161\/01.CIR.0000127126.73759.23","article-title":"MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo","volume":"109","author":"Lips","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0090","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1093\/emboj\/19.23.6341","article-title":"The MEK1-ERK1\/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice","volume":"19","author":"Bueno","year":"2000","journal-title":"EMBO J"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0095","doi-asserted-by":"crossref","first-page":"31246","DOI":"10.1074\/jbc.M806085200","article-title":"DUSP6 (MKP3) null mice show enhanced ERK1\/2 phosphorylation at baseline and increased myocyte proliferation in the heart affecting disease susceptibility","volume":"283","author":"Maillet","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0100","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/01.RES.0000038488.38975.1A","article-title":"Involvement of extracellular signal-regulated kinases 1\/2 in cardiac hypertrophy and cell death","volume":"91","author":"Bueno","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0105","doi-asserted-by":"crossref","first-page":"14074","DOI":"10.1073\/pnas.0610906104","article-title":"Genetic inhibition of cardiac ERK1\/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo","volume":"104","author":"Purcell","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0110","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1126\/science.286.5443.1374","article-title":"Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice","volume":"286","author":"Pages","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0115","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1046\/j.1365-2443.2003.00680.x","article-title":"Essential role for ERK2 mitogen-activated protein kinase in placental development","volume":"8","author":"Hatano","year":"2003","journal-title":"Genes Cells"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0120","doi-asserted-by":"crossref","first-page":"11953","DOI":"10.1523\/JNEUROSCI.2349-11.2011","article-title":"ERK2 contributes to the control of social behaviors in mice","volume":"31","author":"Satoh","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0125","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1161\/CIRCRESAHA.108.188292","article-title":"Cardiac-specific deletion of Mkk4 reveals its role in pathological hypertrophic remodeling, but not in physiological cardiac growth","volume":"104","author":"Liu","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0130","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1161\/CIRCULATIONAHA.111.048785","article-title":"Pak1 as a novel therapeutic target for antihypertrophic treatment in the heart","volume":"124","author":"Liu","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0135","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2-\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0140","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/CIRCRESAHA.110.231514","article-title":"Extracellular signal-regulated kinases 1 and 2 regulate the balance between eccentric and concentric cardiac growth","volume":"108","author":"Kehat","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0145","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/cvr\/cvr103","article-title":"IQGAP1 regulates ERK1\/2 and AKT signalling in the heart and sustains functional remodelling upon pressure overload","volume":"91","author":"Sbroggio","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0150","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nm.1893","article-title":"A new type of ERK1\/2 autophosphorylation causes cardiac hypertrophy","volume":"15","author":"Lorenz","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0155","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/CIRCULATIONAHA.106.615138","article-title":"Akt signaling and growth of the heart","volume":"113","author":"Walsh","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0160","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/heartjnl-2011-300639","article-title":"Physiological cardiac remodelling in response to endurance exercise training: cellular and molecular mechanisms","volume":"98","author":"Ellison","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0165","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.cell.2010.11.036","article-title":"C\/EBP\u03b2 controls exercise-induced cardiac growth and protects against pathological cardiac remodeling","volume":"143","author":"Bostrom","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0170","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1161\/RES.0b013e31820ff484","article-title":"The transcription factor C\/EBPbeta serves as a master regulator of physiologic cardiac hypertrophy","volume":"108","author":"Molkentin","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0175","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.cell.2009.04.060","article-title":"Neuregulin1\/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury","volume":"138","author":"Bersell","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0180","doi-asserted-by":"crossref","first-page":"31099","DOI":"10.1074\/jbc.M111974200","article-title":"Regulation of Raf-Akt cross-talk","volume":"277","author":"Moelling","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0185","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.phrs.2012.04.005","article-title":"ERK1\/2 MAP kinases: structure, function, and regulation","volume":"66","author":"Roskoski","year":"2012","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0190","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/ncb1005","article-title":"Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK","volume":"5","author":"Allan","year":"2003","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0195","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/cdd.2008.148","article-title":"Tumour cell survival signalling by the ERK1\/2 pathway","volume":"16","author":"Balmanno","year":"2009","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0200","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1479-5876-10-15","article-title":"Specifically targeting ERK1 or ERK2 kills melanoma cells","volume":"10","author":"Qin","year":"2012","journal-title":"J Transl Med"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0205","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1006\/jmcc.2000.1215","article-title":"CTGF expression is induced by TGF-beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis","volume":"32","author":"Chen","year":"2000","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0210","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/CIRCULATIONAHA.105.608968","article-title":"MEF2 activates a genetic program promoting chamber dilation and contractile dysfunction in calcineurin-induced heart failure","volume":"114","author":"Van Oort","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0215","doi-asserted-by":"crossref","first-page":"8076","DOI":"10.1167\/iovs.12-10790","article-title":"Effect of connective tissue growth factor on protein kinase expression and activity in human corneal fibroblasts","volume":"53","author":"Radhakrishnan","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.yjmcc.2014.03.002_bb0220","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/nature07511","article-title":"MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts","volume":"456","author":"Thum","year":"2008","journal-title":"Nature"}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282814000790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282814000790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T03:25:50Z","timestamp":1538796350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282814000790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":44,"alternative-id":["S0022282814000790"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2014.03.002","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted deletion of ERK2 in cardiomyocytes attenuates hypertrophic response but provokes pathological stress induced cardiac dysfunction","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2014.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2014 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}